Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]
Phase 2 clinical trial completed evaluating maximal usage pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis [Phase 4]
Phase 4 real-world study assessing long-term quality of life in adults with psoriasis treated with tildrakizumab.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial update on AVT04 evaluating efficacy, safety, and immunogenicity in moderate-to-severe chronic plaque psoriasis; study complete…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis [Phase 3]
A Phase 3 trial evaluating BMS-986165 (deucravacitinib) versus placebo and active comparator in psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated [Phase 4]
Phase 4 non-inferiority trial assessing dose reduction of adalimumab in psoriasis patients who are overtreated has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis [Phase 2]
Phase 2 trial of EDP1815 for mild to moderate plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of apremilast in adults with moderate to severe genital psoriasis has completed and posted …
-
FDA approval · 2022-11-29FDA Approved: JYLAMVO — Original Application (SHORLA ONCOLOGY INC.)
FDA approved JYLAMVO (methotrexate) under an Original Application from SHORLA ONCOLOGY INC.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is [Phase 2]
Phase 2 trial assessing longer-term tolerability and efficacy of BI 730357 in plaque psoriasis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Vascular Inflammation in Psoriasis - Apremilast [Phase 4]
Phase 4 clinical trial update on apremilast for vascular inflammation in psoriasis has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 study update of a recombinant anti-IL-17A monoclonal antibody in Chinese patients with moderate-to-severe psoriasis.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis [Phase 3]
Phase 3 trial updates for BMS-986165 in Japanese participants with moderate-to-severe psoriasis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea [Phase 3]
Phase 3 trial POETYK-PSO-3 evaluating BMS-986165 vs placebo in plaque psoriasis across several Asian regions has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Excimer Laser With Topical Agents in Psoriasis Vulgaris [Phase 4]
Phase 4 clinical trial evaluating excimer laser with topical agents for psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating Metaderm product for psoriasis, with completed status and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis [Phase 2]
Phase 2 trial update of CD 2027 spray evaluated for efficacy and safety in plaque-type psoriasis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: A Phase III Study in Subjects With Mild to Moderate Psoriasis. [Phase 3]
A Phase III clinical trial update for subjects with mild to moderate psoriasis is reported, with phase and status currently UNKNOWN.
-
CLINICAL_TRIALS withdrawal · 2022-08-05Clinical Trial Update: Proton Pump Inhibitors Use in Patients With Psoriasis [Phase 4]
A Phase 4 Clinical Trial investigating proton pump inhibitors in patients with psoriasis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam [Phase 4]
Phase 4 trial comparing two clobetasol propionate 0.05% formulations (Clobex spray vs Olux foam) in psoriasis patients; completed.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis [Phase 2]
Phase 2 trial evaluating the effect of riboflavin on moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis [Phase 2]
Phase 2 dose-ranging study evaluating the efficacy, safety, and tolerability of PF-06700841 topical cream in psoriasis has been completed wi…
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis [Phase 4]
Phase 4 trial evaluating narrowband UVB compared with methotrexate on serum chitotriosidase levels in psoriasis.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is [Phase 2]
Phase 2 trial assessing tolerability and efficacy of BI 730357 in patients with plaque psoriasis has been completed.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients . [Phase 4]
A Phase 4 clinical trial comparing acitretin to narrowband UVB on neopterin levels in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 [Phase 2]
Phase 2 trial assessing adrenal suppression and systemic absorption after multiple dosing of DFD-06 in psoriasis; study terminated with post…